Delivery Order SPE2DB22D1106-SPE2DB24FEGJ7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Trokendi XR 25 mg capsules, with a firm fixed price of $1,728.79 and a completion date of March 4, 2024. This award is not part of a set-aside program. Amerisourcebergen Drug Corp serves as the prime contractor, providing a wide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,891.22 firm fixed-price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has an ultimate completion date of July 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,751.80 firm fixed price delivery order is for the supply of Trokendi XR 100 mg capsules. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Trokendi XR 100 mg capsules. The contract, valued at $1,851.60, is a Delivery Order that runs through October 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of Trokendi XR 200 mg capsules to the Defense Logistics Agency (DLA). The $28,275.74 firm-fixed-price delivery order, awarded on April 22, 2024, has an ultimate completion date of April 23, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $7,979.87 firm fixed price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has an ultimate completion date of April 26, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trokendi XR 50 mg capsules. The contract, valued at $1,539.84, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain to fulfill government contracts for a range of prescription medications, over-the-counter drugs, and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,107.44 fixed-price delivery order is for the supply of Trokendi XR 200 mg capsules. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,347.76 and is for the delivery of Trokendi XR 25 mg capsules. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of March 19, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $12,769.80, is for the delivery of Trokendi XR 200 mg capsules. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEGJ7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,090.69, is a firm fixed price delivery order for the pharmaceutical product Trokendi XR 200 mg capsules. The award has an ultimate completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/22/24 |